New findings from two double-blind studies investigating the efficacy, safety and tolerability of pramipexole dihydrochloride tablets in an extended release, once-daily formulation, for the treatment of Parkinson’s disease (PD), are being presented at the American …

Pharmalink AB announced that it has completed its open Phase II trial evaluating the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading to end-stage renal disease. Nefecon is an enteric formulation of …

Clinical Genomics Pty Ltd, an Australian biotechnology company, announced that Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services, has agreed to provide milestone payments over the next two years to …

Results from two prospective, double-blind placebo controlled multi-center studies in patients with cervical dystonia and blepharospasm, and pooled European efficacy and safety data in patients with focal dystonia and upper limb spasticity will be presented …

Researchers from Dendreon Corporation (Nasdaq: DNDN) presented preclinical data demonstrating the potential of D-3263, Dendreon’s orally bioavailable small molecule, which targets TRPM8 (a transmembrane cation channel protein), to treat benign prostatic hyperplasia (BPH). D-3263 …

Endo Pharmaceuticals (Nasdaq: ENDP) released new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone undecanoate (NEBIDO(R) — 750 mg) injection, a long-acting testosterone replacement therapy in …

The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (Health Science Center) have announced an exclusive license and sponsored research agreement with Merck & Co., …

Medical students from the University of Connecticut (UConn) and across the Northeast are joining the Connecticut Coalition for Prescription Reform on Tuesday, April 28th to lobby state representatives for mandated gift bans and disclosure of …

Representatives from four international agencies, including the director of the U.S. National Toxicology Program (NTP), have signed a memorandum of cooperation that could reduce the number of animals required for consumer product safety testing worldwide.
Read …

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that a Phase 3 trial evaluating Nexavar(R) (sorafenib) tablets in patients with unresectable stage III or stage IV melanoma was stopped early following …

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that data from clinical trials of its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), will be presented at the American Society of Regional Anesthesia and Pain Medicine (ASRA) 34th …

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), announced that updated preliminary data from its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer showed that nine of 14 evaluable patients …

WHAT: A new yearly intercampus symposium exploring how business and medicine can collaborate to solve today’s health care challenges. Panel members will discuss and answer questions regarding the state of collaboration between industry, academia and …

Talley Environmental Care™ is pleased to announce that it has been granted a U.S. Environment Protection Agency (EPA) approved establishment number 85343-GBR-001. Establishments that produce pesticides, active ingredients or devices, including …

Some drugmakers — encouraged by health insurers — have begun linking the prices of their medications to the drugs’ efficacy, the New York Times reports. According to some experts, the strategy could be a positive …

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced that ANA598, the Company’s investigational non-nucleoside polymerase inhibitor, demonstrated potent antiviral activity at all dose levels and was well tolerated in a Phase Ib study in which patients …

IBM (NYSE: IBM) and contract manufacturer and third party logistics provider Golden State Medical Supply (GSMS) announced the two companies have worked together to help drug companies comply with stringent prescription drug pedigree regulations …

Pharmatech Oncology, Inc., a Research Management Organization (RMO) headquartered in Denver, Colorado, announces the launch of their Data Management business unit to the bioscience and pharmaceutical industries. The Pharmatech Oncology Data Management business unit is …

InterMune, Inc. (Nasdaq: ITMN) announced that results from a 14-day Phase 1b clinical study of ITMN-191 (R7227) in combination with the current standard of care were presented by Stefan Zeuzem, M.D., of the J.W. …

Intarcia Therapeutics, Inc. announced the completion of patient accrual to a phase 1b clinical study evaluating ITCA 650 (DUROS(R) continuous delivery of exenatide). The study is being conducted at multiple centers in the United States …